Multimorbidity and animal models

Abstract

Multimorbidity—the co-occurrence of more than two chronic conditions in the same individual—is associated with premature death, diminished function, reduced quality of life, and increased societal burden. This complex state involves dynamic interactions across multiple conditions, organ systems, and physiological pathways; yet research progress remains constrained by inadequate animal models that recapitulate human complexity. This review summarizes the predominant patterns of multimorbidity and evaluates current animal models spanning invertebrates, rodents, and large mammals. While no single model fully captures the multifaceted nature of human multimorbidity, we propose several strategic directions to address existing limitations: implementing a cross-species validation framework (from simple organisms to rodents to large mammals), standardizing protocols integrating multimodal risk factors, developing advanced non-animal models, and enhancing ethical oversight. Advancing multimorbidity models is crucial for decoding disease interactions and accelerating translation of research findings into improved patients outcomes.

Keywords

animal models / biological complexity / multimorbidity

References

[1] Skou ST, Mair FS, Fortin M, et al. Multimorbidity. Nat Rev Dis Primers. 2022; 8(1):48.

[2] Radner H, Yoshida K, Smolen JS, Solomon DH. Multimorbidity and rheumatic conditions—enhancing the concept of comorbidity. Nat Rev Rheumatol. 2014; 10(4): 252-256.

[3] Zöller B, Connors JM. Multimorbidity, comorbidity, frailty, and venous thromboembolism. Haematologica. 2024; 109(12): 3852-3859.

[4] Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine. 2023; 57:101860.

[5] Langenberg C, Hingorani AD, Whitty CJM. Biological and functional multimorbidity—from mechanisms to management. Nat Med. 2023; 29(7): 1649-1657.

[6] eBioMedicine. Multimorbidity: a complex challenge to support and optimise individual health. EBioMedicine. 2024; 99:104973.

[7] Zhao Y, Atun R, Oldenburg B, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. 2020; 8: e840-e849.

[8] Freisling H, Viallon V, Lennon H, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020; 18(1):5.

[9] Tran J, Norton R, Conrad N, et al. Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort study. PLoS Med. 2018; 15(3):e1002513.

[10] Jin L, Guo X, Dou J, et al. Multimorbidity analysis according to sex and age towards cardiovascular diseases of adults in Northeast China. Sci Rep. 2018; 8(1):8607.

[11] North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012; 110(8): 1097-1108.

[12] Khunti K, Chudasama YV, Gregg EW, et al. Diabetes and multiple long-term conditions: a review of our current global health challenge. Diabetes Care. 2023; 46(12): 2092-2101.

[13] Nowakowska M, Zghebi SS, Ashcroft DM, et al. The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. 2019; 17(1):145.

[14] Zhang H, Tu Z, Liu S, et al. Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity. Cardiovasc Diabetol. 2025; 24(1):33.

[15] Marruganti C, Suvan JE, D'Aiuto F. Periodontitis and metabolic diseases (diabetes and obesity): tackling multimorbidity. Periodontol. 2023: 1-16.

[16] Asogwa OA, Quansah DY, Boakye D, Ezewuiro ON, Boateng D. Prevalence, patterns, and determinants of multimorbidity among childhood and adult cancer survivors: a systematic review. Crit Rev Oncol Hematol. 2023; 192:104147.

[17] Jiang C, Deng L, Karr MA, et al. Chronic comorbid conditions among adult cancer survivors in the United States: results from the National Health Interview Survey, 2002-2018. Cancer. 2022; 128(4): 828-838.

[18] Moon SM, Choi H, Kim SH, et al. Increased lung cancer risk and associated risk factors in tuberculosis survivors: a Korean population-based study. Clin Infect Dis. 2023; 77(9): 1329-1339.

[19] Carbone A, Vaccher E, Gloghini A. Hematologic cancers in individuals infected by HIV. Blood. 2022; 139(7): 995-1012.

[20] Chang WC, Hsieh TC, Hsu WL, Chang FL, Tsai HR, He MS. Diabetes and further risk of cancer: a nationwide population-based study. BMC Med. 2024; 22(1):214.

[21] The top 10 causes of death. Accessed May 23, 2024. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

[22] Kahnert K, Jörres RA, Behr J, Welte T. The diagnosis and treatment of COPD and its comorbidities. Dtsch Arztebl Int. 2023; 120(25): 434-444.

[23] Fabbri LM, Celli BR, Agustí A, et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence. Lancet Respir Med. 2023; 11(11): 1020-1034.

[24] De Luca SN, Chan SMH, Dobric A, et al. Cigarette smoke-induced pulmonary impairment is associated with social recognition memory impairments and alterations in microglial profiles within the suprachiasmatic nucleus of the hypothalamus. Brain Behav Immun. 2023; 109: 292-307.

[25] Kaluvu L, Asogwa OA, Marzà-Florensa A, et al. Multimorbidity of communicable and non-communicable diseases in low- and middle-income countries: a systematic review. J Multimorb Comorb. 2022; 12: 1-14.

[26] Althoff KN, Stewart C, Humes E, et al. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: a modeling study. PLoS Med. 2024; 21(1):e1004325.

[27] Cottrell CA, Hu X, Lee JH, et al. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice. Sci Transl Med. 2024; 16(748):eadn0223.

[28] Immonen TT, Fennessey CM, Lipkey L, et al. No evidence for ongoing replication on ART in SIV-infected macaques. Nat Commun. 2024; 15(1):5093.

[29] Tuberculosis. Accessed September 20, 2024. https://www.who.int/news-room/fact-sheets/detail/tuberculosis

[30] Stubbs B, Siddiqi K, Elsey H, et al. Tuberculosis and non-communicable disease multimorbidity: an analysis of the world health survey in 48 low- and middle-income countries. Int J Environ Res Public Health. 2021; 18(5):2439.

[31] Chudasama YV, Zaccardi F, Gillies CL, et al. Patterns of multimorbidity and risk of severe SARS-CoV-2 infection: an observational study in the U.K. BMC Infect Dis. 2021; 21(1):908.

[32] Kazakou P, Lambadiari V, Ikonomidis I, et al. Diabetes and COVID-19; a bidirectional interplay. Front Endocrinol (Lausanne). 2022; 13:780663.

[33] Halstead S, Cao C, Høgnason Mohr G, et al. Prevalence of multimorbidity in people with and without severe mental illness: a systematic review and meta-analysis. Lancet Psychiatry. 2024; 11(6): 431-442.

[34] Andrade LH, Benseñor IM, Viana MC, Andreoni S, Wang YP. Clustering of psychiatric and somatic illnesses in the general population: multimorbidity and socioeconomic correlates. Braz J Med Biol Res. 2010; 43(5): 483-491.

[35] Leyhe T, Reynolds CF, Melcher T, et al. A common challenge in older adults: classification, overlap, and therapy of depression and dementia. Alzheimers Dement. 2017; 13(1): 59-71.

[36] Berger T, Lee H, Young AH, Aarsland D, Thuret S. Adult hippocampal neurogenesis in major depressive disorder and Alzheimer's disease. Trends Mol Med. 2020; 26(9): 803-818.

[37] Zhao W, Zhao L, Chang X, Lu X, Tu Y. Elevated dementia risk, cognitive decline, and hippocampal atrophy in multisite chronic pain. Proc Natl Acad Sci USA. 2023; 120(9):e2215192120.

[38] Blanchet PJ, Brefel-Courbon C. Chronic pain and pain processing in Parkinson's disease. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018; 87(Pt B): 200-206.

[39] Bourque VR, Poulain C, Proulx C, et al. Genetic and phenotypic similarity across major psychiatric disorders: a systematic review and quantitative assessment. Transl Psychiatry. 2024; 14(1): 1-10.

[40] Romano I, Buchan C, Baiocco-Romano L, Ferro MA. Physical-mental multimorbidity in children and youth: a scoping review. BMJ Open. 2021; 11(5):e043124.

[41] Fleetwood KJ, Guthrie B, Jackson CA, et al. Depression and physical multimorbidity: a cohort study of physical health condition accrual in UK Biobank. PLoS Med. 2025; 22(2):e1004532.

[42] Jayatilleke N, Hayes RD, Dutta R, et al. Contributions of specific causes of death to lost life expectancy in severe mental illness. Eur Psychiatry. 2017; 43: 109-115.

[43] Park CS, Choi EK, Do Han K, et al. Increased cardiovascular events in young patients with mental disorders: a nationwide cohort study. Eur J Prev Cardiol. 2023; 30(15): 1582-1592.

[44] Xiang W, Shen Y, Li Y, Chen S, Cao Q, Xu L. Causal association between mental disorders and cerebrovascular diseases: evidence from Mendelian randomization study. J Affect Disord. 2025; 368: 461-470.

[45] Penninx BWJH. Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017; 74(Pt B): 277-286.

[46] Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020; 25(7): 1487-1499.

[47] Chierzi F, Stivanello E, Musti MA, et al. Cancer mortality in common mental disorders: a 10-year retrospective cohort study. Soc Psychiatry Psychiatr Epidemiol. 2023; 58(2): 309-318.

[48] Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003; 54(3): 317-329.

[49] Poulos J, Normand SLT, Zelevinsky K, et al. Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses. Psychol Med. 2023; 53(16): 7677-7684.

[50] Shen P, Yue Y, Park Y. A living model for obesity and aging research: Caenorhabditis elegans. Crit Rev Food Sci Nutr. 2018; 58(5): 741-754.

[51] Yu J, Chai P, Xie M, et al. Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021; 22(1):85.

[52] Shen P, Yue Y, Zheng J, Park Y. Caenorhabditis elegans: a convenient in vivo model for assessing the impact of food bioactive compounds on obesity, aging, and Alzheimer's disease. Annu Rev Food Sci Technol. 2018; 9: 1-22.

[53] Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022; 23(1): 3-20.

[54] O'Meara TR, Nanishi E, McGrath ME, et al. Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance. J Allergy Clin Immunol. 2023; 152(5): 1107-1120.e6.

[55] Cui S, Lin H, Cui Y, et al. Depression promotes lung carcinoma progression by regulating the tumor microenvironment in tumor-bearing models of C57BL/6J mice. Neurosci Lett. 2021; 754:135851.

[56] Threadgill DW, Churchill GA. Ten years of the collaborative cross. Genetics. 2012; 190(2): 291-294.

[57] Milhem A, Abu Toamih-Atamni HJ, Karkar L, Houri-Haddad Y, Iraqi FA. Studying host genetic background effects on multimorbidity of intestinal cancer development, type 2 diabetes and obesity in response to oral bacterial infection and high-fat diet using the collaborative cross (CC) lines. Animal Model Exp Med. 2021; 4(1): 27-39.

[58] Wegener G, Mathe AA, Neumann ID. Selectively bred rodents as models of depression and anxiety. Curr Top Behav Neurosci. 2011; 12: 139-187.

[59] Diedrichs-Möhring M, Kaufmann U, Wildner G. The immunopathogenesis of chronic and relapsing autoimmune uveitis—lessons from experimental rat models. Prog Retin Eye Res. 2018; 65: 107-126.

[60] Osterrieder N, Bertzbach LD, Dietert K, et al. Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters. Viruses. 2020; 12(7):779.

[61] Moran KM, Delville Y. A hamster model for stress-induced weight gain. Horm Behav. 2024; 160:105488.

[62] Cuenca-Bermejo L, Pizzichini E, Gonzalez-Cuello AM, De Stefano ME, Fernandez-Villalba E, Herrero MT. Octodon degus: a natural model of multimorbidity for ageing research. Ageing Res Rev. 2020; 64:101204.

[63] Inestrosa NC, Reyes AE, Chacón MA, et al. Human-like rodent amyloid-β-peptide determines Alzheimer pathology in aged wild-type Octodon degu. Neurobiol Aging. 2005; 26(7): 1023-1028.

[64] Tan Z, Garduño BM, Aburto PF, et al. Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer's disease. Acta Neuropathol Commun. 2022; 10(1):182.

[65] Spear GS, Caple MV, Sutherland LR. The pancreas in the degu. Exp Mol Pathol. 1984; 40(3): 295-310.

[66] Wayne RK, Ostrander EA. Lessons learned from the dog genome. Trends Genet. 2007; 23(11): 557-567.

[67] Kennedy BK, Berger SL, Brunet A, et al. Aging: a common driver of chronic diseases and a target for novel interventions. Cell. 2014; 159(4):709.

[68] Guy MK, Page RL, Jensen WA, et al. The Golden retriever lifetime study: establishing an observational cohort study with translational relevance for human health. Philos Trans R Soc Lond Ser B Biol Sci. 2015; 370(1673):20140230.

[69] Creevy KE, Akey JM, Kaeberlein M, et al. An open science study of ageing in companion dogs. Nature. 2022; 602(7895): 51-57.

[70] Lunney JK, Van Goor A, Walker KE, Hailstock T, Franklin J, Dai C. Importance of the pig as a human biomedical model. Sci Transl Med. 2021; 13(621):eabd5758.

[71] Van De Wouw J, Steenhorst JJ, Sorop O, et al. Impaired Pulmonary Vasomotor Control in Exercising Swine with Multiple Comorbidities. Basic Res Cardiol. 2021; 116:51.

[72] Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes. 2001; 50(7): 1654-1665.

[73] Davis BT, Wang XJ, Rohret JA, et al. Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs. PLoS One. 2014; 9(4):e93457.

[74] Flisikowska T, Merkl C, Landmann M, et al. A porcine model of familial adenomatous polyposis. Gastroenterology. 2012; 143(5): 1173-1175.e7.

[75] Jakobsen JE, Johansen MG, Schmidt M, et al. Expression of the Alzheimer's disease mutations AβPP695sw and PSEN1M146I in double-transgenic Göttingen minipigs. J Alzheimer's Dis. 2016; 53(4): 1617-1630.

[76] Languille S, Blanc S, Blin O, et al. The grey mouse lemur: a non-human primate model for ageing studies. Ageing Res Rev. 2012; 11(1): 150-162.

[77] Perez-Cruz C, Rodriguez-Callejas J d D. The common marmoset as a model of neurodegeneration. Trends Neurosci. 2023; 46(5): 394-409.

[78] Chilton J, Wilcox A, Lammey M, Meyer D. Characterization of a cardiorenal-like syndrome in aged chimpanzees (Pan troglodytes). Vet Pathol. 2016; 53(2): 417-424.

[79] Newman LE, Testard C, DeCasien AR, et al. The biology of aging in a social world: insights from free-ranging rhesus macaques. Neurosci Biobehav Rev. 2023; 154:105424.

[80] Chen YL, You J, Guo Y, et al. Identifying proteins and pathways associated with multimorbidity in 53,026 adults. Metabolism. 2025; 164:156126.

[81] Ureña E, Xu B, Regan JC, et al. Trametinib ameliorates aging-associated gut pathology in Drosophila females by reducing Pol III activity in intestinal stem cells. Proc Natl Acad Sci USA. 2024; 121(4):e2311313121.

[82] Liu K, Fang X, Aazmi A, et al. Organoids: principle, application and perspective. Innovation Life. 2024; 2(3):100088-1.

[83] Juguilon C, Khosravi R, Radisic M, Wu JC. In vitro modeling of interorgan crosstalk: multi-organ-on-a-Chip for studying cardiovascular-kidney-metabolic syndrome. Circ Res. 2025; 136(11): 1476-1493.

[84] Cabreiro F, Au C, Leung KY, et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 2013; 153(1): 228-239.

[85] Wan QL, Meng X, Wang C, et al. Histone H3K4me3 modification is a transgenerational epigenetic signal for lipid metabolism in Caenorhabditis elegans. Nat Commun. 2022; 13(1):768.

[86] Yong YY, Yan L, Wang BD, et al. Penthorum chinense Pursh inhibits ferroptosis in cellular and Caenorhabditis elegans models of Alzheimer's disease. Phytomedicine. 2024; 127:155463.

[87] Jeong A, Park SJ, Lee EJ, Kim KW. Nanoplastics exacerbate Parkinson's disease symptoms in C. elegans and human cells. J Hazard Mater. 2024; 465:133289.

[88] Baskoylu SN, Chapkis N, Unsal B, et al. Disrupted autophagy and neuronal dysfunction in C. elegans knockin models of FUS amyotrophic lateral sclerosis. Cell Rep. 2022; 38(4):110195.

[89] Shi X, Liu C, Chen J, et al. Endothelial MICU1 alleviates diabetic cardiomyopathy by attenuating nitrative stress-mediated cardiac microvascular injury. Cardiovasc Diabetol. 2023; 22(1):216.

[90] Matsukawa T, Yagi T, Uchida T, et al. Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models. JCI Insight. 2023; 8(17):e161282.

[91] Jeong BK, Choi WI, Choi W, et al. A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma. Nat Commun. 2024; 15(1):6506.

[92] Shi C, Aboumsallem JP, de Wit S, et al. Evaluation of renal cancer progression in a mouse model of heart failure. Cancer Commun (Lond). 2021; 41(8): 796-799.

[93] Wu Y, Deng J, Ma J, et al. Unraveling the pathogenesis of post-stroke depression in a hemorrhagic mouse model through frontal lobe circuitry and JAK-STAT signaling. Adv Sci (Weinh). 2024; 11(33):2402152.

[94] He Q, Ji L, Wang Y, et al. Acetate enables metabolic fitness and cognitive performance during sleep disruption. Cell Metab. 2024; 36(9): 1998-2014.e15.

[95] Nakayama Y, Fujiu K, Oshima T, et al. Heart failure promotes multimorbidity through innate immune memory. Sci Immunol. 2024; 9(95):eade3814.

[96] Bohórquez JA, Adduri S, Ansari D, et al. A novel humanized mouse model for HIV and tuberculosis co-infection studies. Front Immunol. 2024; 15:1395018.

[97] Kearns AC, Liu F, Dai S, et al. Caspase-1 activation is related with HIV-associated atherosclerosis in an HIV transgenic mouse model and HIV patient cohort. Arterioscler Thromb Vasc Biol. 2019; 39(9): 1762-1775.

[98] Barreto ICG, Viegas P, Ziff EB, Konkiewitz EC. Animal models for depression associated with HIV-1 infection. J Neuroimmune Pharmacol. 2014; 9(2): 195-208.

[99] Vankayalapati A, Durojaye O, Mukherjee T, et al. Metabolic changes enhance necroptosis of type 2 diabetes mellitus mice infected with Mycobacterium tuberculosis. PLoS Pathog. 2024; 20(5):e1012148.

[100] Gao WC, Ma X, Wang P, et al. Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice. Zool Res. 2021; 42(5): 633-636.

[101] Liao Y, Wang Y, Tao QQ, et al. CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk. Alzheimers Dement. 2023; 19(10): 4407-4420.

[102] Bobkova NV, Chuvakova LN, Kovalev VI, et al. A mouse model of sporadic Alzheimer's disease with elements of major depression. Mol Neurobiol. 2024; 62: 1337-1358.

[103] Wang Y, Wang X, Wang K, et al. Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and dopamine/ERK/TH positive feedback loop. J Exp Clin Cancer Res. 2023; 42(1):161.

[104] Yang J, Sun P, Xu X, et al. TAK1 improves cognitive function via suppressing RIPK1-driven neuronal apoptosis and necroptosis in rats with chronic hypertension. Aging Dis. 2023; 14(5): 1799-1817.

[105] Chen F, Liu J, Li FQ, et al. β2-microglobulin exacerbates neuroinflammation, brain damage, and cognitive impairment after stroke in rats. Neural Regen Res. 2023; 18(3): 603-608.

[106] Althammer F, Roy RK, Kirchner MK, et al. Angiotensin II-mediated neuroinflammation in the hippocampus contributes to neuronal deficits and cognitive impairment in heart failure rats. Hypertension. 2023; 80(6): 1258-1273.

[107] Shi ZM, Jing JJ, Xue ZJ, et al. Stellate ganglion block ameliorated central post-stroke pain with comorbid anxiety and depression through inhibiting HIF-1α/NLRP3 signaling following thalamic hemorrhagic stroke. J Neuroinflammation. 2023; 20(1):82.

[108] Wang Y, Liu X, Zhang D, Chen J, Liu S, Berk M. The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction. BMC Med. 2013; 11(1):32.

[109] Zhang M, Liu Y, Zhao M, et al. Depression and anxiety behaviour in a rat model of chronic migraine. J Headache Pain. 2017; 18(1):27.

[110] Sarkisova KY, Gabova AV, Fedosova EA, Shatskova AB, Narkevich VB, Kudrin VS. Antidepressant and anxiolytic effects of L-methionine in the WAG/Rij rat model of depression comorbid with absence epilepsy. Int J Mol Sci. 2023; 24(15):12425.

[111] Goodus MT, Alfredo AN, Carson KE, et al. Spinal cord injury-induced metabolic impairment and steatohepatitis develops in non-obese rats and is exacerbated by premorbid obesity. Exp Neurol. 2024; 379:114847.

[112] Chen RY, Chang HS, Huang HC, Hsueh YH, Tu YK, Lee KZ. Comorbidity of cardiorespiratory and locomotor dysfunction following cervical spinal cord injury in the rat. J Appl Physiol (1985). 2023; 135(6): 1268-1283.

[113] Duffy BC, King KM, Nepal B, Nonnemacher MR, Kortagere S. Acute administration of HIV-1 tat protein drives glutamatergic alterations in a rodent model of HIV-associated neurocognitive disorders. Mol Neurobiol. 2024; 61(10): 8467-8480.

[114] Selejan SR, Linz D, Mauz M, et al. Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome. Basic Res Cardiol. 2022; 117(1):36.

[115] Qian J, Huang C, Wang M, et al. Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment. Redox Biol. 2024; 71:103103.

[116] Hanses F, Roux C, Dunman PM, Salzberger B, Lee JC. Staphylococcus aureus gene expression in a rat model of infective endocarditis. Genome Med. 2014; 6(10):93.

[117] Liu S, Wang BH, Kelly DJ, Krum H, Kompa AR. Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage. J Cell Mol Med. 2018; 22(1): 628-645.

[118] Shalhoub V, Shatzen EM, Ward SC, et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest. 2012; 122(7): 2543-2553.

[119] Qu C, Zheng D, Li S, et al. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology. 2018; 68(3): 1125-1139.

[120] Oishi K, Horiuchi S, Frere J, Schwartz RE, tenOever BR. A diminished immune response underlies age-related SARS-CoV-2 pathologies. Cell Rep. 2022; 39(13):111002.

[121] Port JR, Adney DR, Schwarz B, et al. High-fat high-sugar diet-induced changes in the lipid metabolism are associated with mildly increased COVID-19 severity and delayed recovery in the Syrian hamster. Viruses. 2021; 13(12):2506.

[122] Sencio V, Benech N, Robil C, et al. Alteration of the gut microbiota's composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters. Gut Microbes. 2022; 14(1):2100200.

[123] Agbor GA, Vinson JA, Patel S, et al. Effect of selenium- and glutathione-enriched yeast supplementation on a combined atherosclerosis and diabetes hamster model. J Agric Food Chem. 2007; 55(21): 8731-8736.

[124] Hurley MJ, Urra C, Garduno BM, et al. Genome sequencing variations in the Octodon degus, an unconventional natural model of aging and Alzheimer's disease. Front Aging Neurosci. 2022; 14:894994.

[125] Kaeberlein M, Creevy KE, Promislow DEL. The dog aging project: translational geroscience in companion animals. Mamm Genome. 2016; 27(7–8): 279-288.

[126] Löscher W. Dogs as a natural animal model of epilepsy. Front Vet Sci. 2022; 9:928009.

[127] Sulkama S, Puurunen J, Salonen M, et al. Canine hyperactivity, impulsivity, and inattention share similar demographic risk factors and behavioural comorbidities with human ADHD. Transl Psychiatry. 2021; 11(1):501.

[128] van de Wouw J, Sorop O, van Drie RWA, et al. Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease. Basic Res Cardiol. 2020; 115(2):21.

[129] van Drie RWA, van de Wouw J, Zandbergen LM, et al. Vasodilator reactive oxygen species ameliorate perturbed myocardial oxygen delivery in exercising swine with multiple comorbidities. Basic Res Cardiol. 2024; 119(5): 869-887.

[130] Baranowski BJ, Allen MD, Nyarko JNK, et al. Cerebrovascular insufficiency and amyloidogenic signaling in Ossabaw swine with cardiometabolic heart failure. JCI Insight. 2021; 6(10):e143141.

[131] Khanna R, Moutal A, White KA, et al. Assessment of nociception and related quality of life measures in a porcine model of neurofibromatosis type 1. Pain. 2019; 160(11):2473.

[132] Ely JJ, Zavaskis T, Lammey ML. Hypertension increases with aging and obesity in chimpanzees (Pan troglodytes). Zoo Biol. 2013; 32(1): 79-87.

[133] Rhoades NS, Davies M, Lewis SA, et al. Functional, transcriptional, and microbial shifts associated with healthy pulmonary aging in rhesus macaques. Cell Rep. 2022; 39(3):110725.

[134] Hao Y, Yu B, Qin M, et al. Extracellular vesicles from antler blastema progenitor cells reverse bone loss and mitigate aging-related phenotypes in mice and macaques. Nat Aging. 2025; 5(9): 1790-1809.

[135] Siracusa ER, Negron-Del Valle JE, Phillips D, et al. Within-individual changes reveal increasing social selectivity with age in rhesus macaques. Proc Natl Acad Sci USA. 2022; 119(49):e2209180119.

[136] Pandrea I, Cornell E, Wilson C, et al. Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood. 2012; 120(7): 1357-1366.

[137] Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010; 6(8):e1001052.

[138] Pandrea I, Landay A, Wilson C, et al. Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities. Curr HIV AIDS Rep. 2015; 12(1): 54-67.

[139] He T, Xu C, Krampe N, et al. High-fat diet exacerbates SIV pathogenesis and accelerates disease progression. J Clin Invest. 2019; 129(12): 5474-5488.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.